FDA Inspection 985577 — Hanlim Pharm Co. Ltd.

Hanlim Pharm Co. Ltd. — FEI 3004886113

The FDA completed an inspection of Hanlim Pharm Co. Ltd. on July 19, 2016 in Yongin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 19, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yongin (Korea (the Republic of))